Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
Nature Medicine|December 29, 1999
Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapyM E Sharkey, I Teo, T Greenough, et al.
The New England Journal of Medicine|December 1, 2006
CD4+ count-guided interruption of antiretroviral treatment, W M El-Sadr, J D Lundgren, et al.
Lancet (London, England)|April 20, 2004
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN StudyF van Leth, P Phanuphak, K Ruxrungtham, et al.
HIV Medicine|October 25, 2019
The EuroSIDA study: 25 years of scientific achievementsK Laut, O Kirk, J Rockstroh, et al.
Plos One|November 13, 2015
Auditing HIV Testing Rates across Europe: Results from the HIDES 2 StudyD Raben, A Mocroft, M Rayment, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2013
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy eraA Mocroft, H J Furrer, J M Miro, et al.
Lancet (London, England)|December 17, 2009
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial, P Mugyenyi, A S Walker, et al.
Pageof 19